Yao Wong

Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.

L. Pusztai, V. Valero, C. Hatzis, 2018, The oncologist.

Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report

S. Shyur, Yao Wong, 2022, Medicina.

Long-term survival of de novo stage IV human epidermal growth factor receptor 2 (HER2)-positive breast cancers treated with HER2 targeted therapy.

L. Pusztai, C. Hatzis, A. Raghavendra, 2017 .